PL
BLU

Parkwood LLC’s BELLUS Health Inc. BLU Stock Holding History

Parkwood LLC’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-38,266
Closed -$315K – 181
2022
Q4 		$315K Buy
+38,266
New +$357K 0.05% 129

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parkwood LLC's BLU Position: Q1 2023 in Review

Parkwood LLC sold out of BELLUS Health Inc. (BLU) in Q1 2023, closing a stake of 38,266 shares — an estimated $315K sold.

Parkwood LLC first reported a position in BLU in Q4 2022 and held it in 1 quarter. The position peaked at $315K in Q4 2022. 106 funds tracked by Wall St. Rank hold BLU as of Q1 2023.

  • Parkwood LLC reported no remaining BELLUS Health Inc. position as of Q1 2023 after selling out during the quarter.
  • Parkwood LLC sold 38,266 BELLUS Health Inc. shares in Q1 2023, an estimated $315K.
  • Parkwood LLC first reported a position in BELLUS Health Inc. in Q4 2022 and held it in 1 quarter.
  • Parkwood LLC's BELLUS Health Inc. position peaked at $315K in Q4 2022.
  • 106 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2023.

Based on Parkwood LLC's 13F filing for Q1 2023, filed 15 May 2023.